Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Healon5 OVD is a **viscoadaptive ophthalmic viscoelastic device** composed of **sodium hyaluronate 2.3%** designed for intraocular use during anterior segment ophthalmic surgical procedures, such as cataract surgery[4][6][7]. It exhibits both highly cohesive and dispersive properties, enabling it to maintain anterior chamber depth, facilitate tissue manipulation, and protect ocular tissues including the corneal endothelium during procedures[1][2][7]. Its unique rheological characteristics—very high viscosity and elasticity at low shear rates, in addition to easy dispersibility and removal at high shear rates—make it especially suitable for complex surgical situations like small pupil management or cases with iris prolapse[1][2][3]. Healon5 does not have pharmacological actions; its mechanism is primarily physical, providing space maintenance and tissue protection during surgery[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on healon5 ovd.